Lastest Paronychia News
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q3 2014 Results – Earnings … Inhibition of wild-type EGFR is associated with cutaneous toxicities such as rash, stomatitis and paronychia, all of which may significantly impact patients' quality of life, can result in treatment discontinuation and can cause patient distress. We … Read more on Seeking Alpha …